Stay updated on NT-814 Efficacy in Menopausal Symptoms Clinical Trial
Sign up to get notified when there's something new on the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page.

Latest updates to the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page
- Check6 days agoChange DetectedThe locations are now listed under a new top-level 'Locations' section with consolidated country/region entries, replacing the previous separate state-specific headings; the HHS Vulnerability Disclosure link is removed and the page revision is updated to v3.3.3.SummaryDifference0.9%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedThe government funding lapse notice was removed from the page. All other study details, locations, and planned outcomes remain the same.SummaryDifference0.3%

- Check56 days agoChange DetectedLayout and navigation of the study details page were updated. Core elements such as study design, interventions, outcomes, and eligibility criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check85 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0; this changes how users view current operations and the release version.SummaryDifference1%

- Check92 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.SummaryDifference0.2%

Stay in the know with updates to NT-814 Efficacy in Menopausal Symptoms Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page.